Amprius Technologies (NYSE:AMPX) Trading Up 1% on Analyst Upgrade

Shares of Amprius Technologies, Inc. (NYSE:AMPX) were up 1% on Tuesday after B. Riley Financial raised their price target on the stock from $16.00 to $22.00. B. Riley Financial currently has a buy rating on the stock. Amprius Technologies traded as high as $18.95 and last traded at $17.9060. Approximately 14,053,794 shares traded hands during trading, an increase of 53% from the average daily volume of 9,190,763 shares. The stock had previously closed at $17.72.

Several other research firms have also issued reports on AMPX. Roth Mkm restated a “buy” rating and issued a $20.00 target price (up from $16.00) on shares of Amprius Technologies in a report on Friday. Oppenheimer reissued an “outperform” rating and issued a $17.00 price objective on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Cantor Fitzgerald raised their price objective on shares of Amprius Technologies from $16.00 to $20.00 and gave the stock an “overweight” rating in a research note on Friday. Craig Hallum boosted their target price on Amprius Technologies from $17.00 to $21.00 and gave the company a “buy” rating in a research report on Friday. Finally, Needham & Company LLC initiated coverage on Amprius Technologies in a research report on Thursday, January 29th. They set a “buy” rating and a $20.00 target price for the company. Eight research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $19.75.

Insider Buying and Selling at Amprius Technologies

In other news, CTO Constantin Ionel Stefan sold 25,366 shares of the business’s stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $10.16, for a total transaction of $257,718.56. Following the completion of the sale, the chief technology officer directly owned 723,330 shares of the company’s stock, valued at approximately $7,349,032.80. The trade was a 3.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kang Sun sold 61,251 shares of the company’s stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $10.16, for a total transaction of $622,310.16. Following the completion of the transaction, the director owned 1,342,400 shares in the company, valued at approximately $13,638,784. The trade was a 4.36% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 2,392,269 shares of company stock valued at $26,384,359. Corporate insiders own 12.80% of the company’s stock.

Trending Headlines about Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Q4 results and analyst attention: Amprius reported results that beat expectations and flagged expanded analyst coverage, which helped validate the company’s growth story to the market. Earnings & Coverage
• Positive Sentiment: Record revenue and EBITDA inflection: Management highlighted record revenue growth and the company’s first quarter of positive adjusted EBITDA — a fundamental milestone that supports higher valuations and institutional interest. Revenue & EBITDA Story
• Positive Sentiment: Multiple price-target raises and reiterated buy ratings: Several firms updated coverage after the quarter — B. Riley raised its target (to $22), Needham reaffirmed a Buy with a $20 target, Roth/MKM and others reiterated Buy views — providing buy-side momentum and cover for investors. (See firm notes cited in recent coverage.)
• Positive Sentiment: Technical/volume breakout supports continuation: MarketBeat and others point to sharply higher trading volume and technical convergence (daily/weekly/monthly) that often precedes sustained moves — increased liquidity and volume validate the rally and can attract momentum traders. Volume & Technical Signal
• Neutral Sentiment: Analyst forecasts shifting positive but mixed timing: Firms like Northland have raised multi-quarter and FY2027 EPS estimates (turning to positive EPS in 2027), which supports a longer-term rerating but leaves the near-term consensus for the current year still negative. (Research note summaries circulated 3/9–3/10.)
• Negative Sentiment: Profitability, valuation and concentration risks remain: Despite milestones, Amprius is still generating negative net margins and the consensus for the current fiscal year remains a loss (-$0.45 EPS). The stock is high-beta and volatile, institutional ownership is still modest, and upside depends on continued execution and contract wins (e.g., NDAA compliance progress and defence/customer ramps).

Institutional Trading of Amprius Technologies

Several institutional investors and hedge funds have recently modified their holdings of AMPX. EWA LLC boosted its holdings in shares of Amprius Technologies by 3.8% in the fourth quarter. EWA LLC now owns 19,958 shares of the company’s stock valued at $157,000 after purchasing an additional 723 shares during the period. Victory Capital Management Inc. increased its holdings in Amprius Technologies by 14.7% during the 3rd quarter. Victory Capital Management Inc. now owns 11,817 shares of the company’s stock worth $124,000 after purchasing an additional 1,516 shares during the period. Graham Capital Management L.P. raised its position in Amprius Technologies by 3.2% during the 4th quarter. Graham Capital Management L.P. now owns 49,596 shares of the company’s stock valued at $391,000 after purchasing an additional 1,551 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of Amprius Technologies by 5.1% in the 4th quarter. The Manufacturers Life Insurance Company now owns 33,280 shares of the company’s stock worth $263,000 after buying an additional 1,621 shares during the period. Finally, First Trust Advisors LP grew its position in shares of Amprius Technologies by 6.7% during the 4th quarter. First Trust Advisors LP now owns 32,744 shares of the company’s stock worth $258,000 after buying an additional 2,066 shares in the last quarter. Institutional investors own 5.04% of the company’s stock.

Amprius Technologies Trading Up 1.0%

The firm has a market cap of $2.34 billion, a P/E ratio of -52.66 and a beta of 3.04. The business has a 50-day moving average price of $11.07 and a 200-day moving average price of $10.82.

Amprius Technologies (NYSE:AMPX) last released its quarterly earnings data on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.03. Amprius Technologies had a negative return on equity of 25.77% and a negative net margin of 60.30%.The firm had revenue of $25.23 million during the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. On average, equities analysts anticipate that Amprius Technologies, Inc. will post -0.45 earnings per share for the current fiscal year.

Amprius Technologies Company Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.